DK0548123T3 - Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelse - Google Patents
Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelseInfo
- Publication number
- DK0548123T3 DK0548123T3 DK91915601T DK91915601T DK0548123T3 DK 0548123 T3 DK0548123 T3 DK 0548123T3 DK 91915601 T DK91915601 T DK 91915601T DK 91915601 T DK91915601 T DK 91915601T DK 0548123 T3 DK0548123 T3 DK 0548123T3
- Authority
- DK
- Denmark
- Prior art keywords
- factor
- milk
- animal
- inflammatory factor
- isolation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/580,382 US5242691A (en) | 1982-06-03 | 1990-09-11 | Anti-inflammatory factor, method of isolation, and use |
PCT/US1991/004174 WO1992004035A1 (fr) | 1990-09-11 | 1991-06-12 | Facteur anti-inflammatoire, procede d'isolation et d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0548123T3 true DK0548123T3 (da) | 1999-02-15 |
Family
ID=24320860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91915601T DK0548123T3 (da) | 1990-09-11 | 1991-06-12 | Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelse |
Country Status (13)
Country | Link |
---|---|
US (1) | US5242691A (fr) |
EP (1) | EP0548123B1 (fr) |
JP (1) | JPH08502718A (fr) |
AT (1) | ATE171875T1 (fr) |
AU (1) | AU660626B2 (fr) |
CA (1) | CA2090011C (fr) |
DE (1) | DE69130323T2 (fr) |
DK (1) | DK0548123T3 (fr) |
ES (1) | ES2124229T3 (fr) |
IE (1) | IE912109A1 (fr) |
IL (1) | IL98647A (fr) |
NZ (2) | NZ250386A (fr) |
WO (1) | WO1992004035A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650175A (en) * | 1982-06-03 | 1997-07-22 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
US5352462A (en) * | 1982-06-03 | 1994-10-04 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
AU648800B2 (en) * | 1990-07-05 | 1994-05-05 | Stolle Milk Biologics, Inc. | Immune suppressive product |
US5747296A (en) * | 1992-05-11 | 1998-05-05 | Corvas International, Inc. | Method of detecting neutophil inhibitory factor mimics |
US6090380A (en) * | 1994-01-12 | 2000-07-18 | Research Corporation Technologies, Inc. | Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
US5980953A (en) * | 1994-10-03 | 1999-11-09 | Stolle Milk Biologics, Inc. | Anti-inflammatory factor, method of isolation, and use |
DE19548221C1 (de) * | 1995-12-22 | 1997-05-15 | Biotest Pharma Gmbh | Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände |
CA2197515A1 (fr) * | 1996-07-15 | 1998-01-16 | Reyad Mahmoud | Methodes pour traiter les produits laitiers |
US6478969B2 (en) | 1996-09-06 | 2002-11-12 | Pall Corporation | Shear separation method and system |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
JP2001342127A (ja) * | 2000-06-02 | 2001-12-11 | Nomoto Kikuo | 腸吸収性抗炎症因子含有免疫性物質及びその応用 |
US20030099635A1 (en) * | 2001-10-04 | 2003-05-29 | Protein Therapeutics, Inc. | Use of oral gammaglobulin for the treatment of immune-mediated diseases |
US6770280B1 (en) | 2001-11-15 | 2004-08-03 | Humanetics Corporation | Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product |
US20080026983A1 (en) * | 2006-07-28 | 2008-01-31 | Gardiner Paul T | Compositions and methods for alleviating joint pain and improving joint flexibility |
JP2011051914A (ja) * | 2009-08-31 | 2011-03-17 | Obihiro Univ Of Agriculture & Veterinary Medicine | 低温殺菌処理ホエータンパク濃縮物を含む腸管炎症抑制剤 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3128230A (en) * | 1961-04-04 | 1964-04-07 | Sunbury Milk Products Co | Milk having antibodies therein and process for producing same |
US3376198A (en) * | 1965-07-21 | 1968-04-02 | Collins Products Inc | Method of producing antibodies in milk |
GB1211876A (en) * | 1967-11-23 | 1970-11-11 | Twyford Lab Ltd | Improvements in and relating to prophylactic and therapeutic preparations |
CH590064A5 (fr) * | 1973-11-28 | 1977-07-29 | Biokema Sa | |
US4324782A (en) * | 1974-01-28 | 1982-04-13 | Beck Lee R | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells |
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
EP0064103B1 (fr) * | 1981-04-28 | 1985-11-06 | The Stolle Research And Development Corporation | Procédé d'obtention d'un lait bovin anti-inflammatoire |
US4956349A (en) * | 1983-10-27 | 1990-09-11 | Stolle Research & Development Corporation | Anti-inflammatory factor, method of isolation, and use |
US4897265A (en) * | 1983-10-27 | 1990-01-30 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
DE3785033T2 (de) * | 1987-07-21 | 1993-10-07 | Stolle Res & Dev | Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung. |
-
1990
- 1990-09-11 US US07/580,382 patent/US5242691A/en not_active Expired - Lifetime
-
1991
- 1991-06-12 CA CA002090011A patent/CA2090011C/fr not_active Expired - Lifetime
- 1991-06-12 JP JP3514820A patent/JPH08502718A/ja active Pending
- 1991-06-12 EP EP91915601A patent/EP0548123B1/fr not_active Expired - Lifetime
- 1991-06-12 WO PCT/US1991/004174 patent/WO1992004035A1/fr active IP Right Grant
- 1991-06-12 AT AT91915601T patent/ATE171875T1/de not_active IP Right Cessation
- 1991-06-12 DK DK91915601T patent/DK0548123T3/da active
- 1991-06-12 AU AU84340/91A patent/AU660626B2/en not_active Ceased
- 1991-06-12 ES ES91915601T patent/ES2124229T3/es not_active Expired - Lifetime
- 1991-06-12 DE DE69130323T patent/DE69130323T2/de not_active Expired - Fee Related
- 1991-06-19 IE IE210991A patent/IE912109A1/en not_active IP Right Cessation
- 1991-06-27 IL IL9864791A patent/IL98647A/en not_active IP Right Cessation
- 1991-06-27 NZ NZ250386A patent/NZ250386A/en not_active IP Right Cessation
- 1991-06-27 NZ NZ238751A patent/NZ238751A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5242691A (en) | 1993-09-07 |
EP0548123B1 (fr) | 1998-10-07 |
AU8434091A (en) | 1992-03-30 |
JPH08502718A (ja) | 1996-03-26 |
ATE171875T1 (de) | 1998-10-15 |
WO1992004035A1 (fr) | 1992-03-19 |
IL98647A0 (en) | 1992-07-15 |
ES2124229T3 (es) | 1999-02-01 |
EP0548123A1 (fr) | 1993-06-30 |
EP0548123A4 (en) | 1993-12-08 |
CA2090011A1 (fr) | 1992-03-12 |
IE912109A1 (en) | 1992-03-11 |
IL98647A (en) | 1999-11-30 |
DE69130323T2 (de) | 1999-05-20 |
DE69130323D1 (de) | 1998-11-12 |
CA2090011C (fr) | 2003-12-30 |
NZ238751A (en) | 1994-03-25 |
NZ250386A (en) | 1997-06-24 |
AU660626B2 (en) | 1995-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0548123T3 (da) | Anti-inflammatorisk faktor, fremgangsmåde til isolering og anvendelse | |
DE3775805D1 (de) | Arzneimittel zur behandlung periodontaler erkrankungen. | |
DE69133516D1 (de) | Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen | |
DE69434773D1 (de) | Vorrichtung zur schnellen thermischen Behandlung zur Herstellung von Halbleiterwafern | |
ATE191475T1 (de) | Verfahren zur isolierung, reinigung und rekristallisation von lutein aus verseiften marigold oleoresin und diesen verwendungen | |
DK158723C (da) | Analogifremgangsmaade til fremstilling af triphenylimidazol-2-yloxyalkansyrer og derivater deraf | |
FI904204A0 (fi) | Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter. | |
DE3856594D1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE69109583D1 (de) | Verfahren zur Behandlung von entzündlichen Darmerkrankungen. | |
DE3873855D1 (de) | Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten. | |
DK610389D0 (da) | Antiinflammatorisk faktor, fremgangsmaade til isolation og anvendelse heraf | |
ATE141613T1 (de) | Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür | |
DE69600983D1 (de) | Kapselpräparate zur Behandlung von Pflanzen | |
AT383123B (de) | Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat | |
ATE209914T1 (de) | Verwendung von pyridylmethylsulfinyl-1h- benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen | |
DK0495953T3 (da) | 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo-(7.2.0.0.3.8)undec-2-en-carboxylsyreestere og fremgangsmåde til fremstilling deraf | |
ATE17007T1 (de) | Neue o-alkyl-o-carbamoyl-glycero-phosphocholine und verfahren zu ihrer herstellung. | |
DK0594528T3 (da) | Fremgangsmåde og anlæg til behandling af halve slagtekroppe | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
DE69632677D1 (de) | Verwendung eines Rifamycin-Derivates zur Herstellung eines Medikamentes zur Behandlung von Krankheiten verursacht durch Helicobacter pylori-Infektionen | |
DE3762526D1 (de) | Hochkonzentrierte saeurezusammensetzungen fuer die behandlung von wasser und die reinigung von anlagen. | |
DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
DK0533610T3 (da) | Anlæg og fremgangsmåde til at producere cyanursyre | |
DE69125969D1 (de) | Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen |